Literature DB >> 26847815

Signaling pathways involving adenosine A2A and A2B receptors in wound healing and fibrosis.

Gibran Shaikh1, Bruce Cronstein2.   

Abstract

Collagen and matrix deposition by fibroblasts is an essential part of wound healing but also contributes to pathologic remodeling of organs leading to substantial morbidity and mortality. Adenosine, a small molecule generated extracellularly from adenine nucleotides as a result of direct stimulation, hypoxia, or injury, acts via a family of classical seven-pass G protein-coupled protein receptors, A2A and A2B, leading to generation of cAMP and activation of downstream targets such as PKA and Epac. These effectors, in turn, lead to fibroblast activation and collagen synthesis. The regulatory actions of these receptors likely involve multiple interconnected pathways, and one of the more interesting aspects of this regulation is opposing effects at different levels of cAMP generated. Additionally, adenosine signaling contributes to fibrosis in organ-specific ways and may have opposite effects in different organs. The development of drugs that selectively target these receptors and their signaling pathways will disrupt the pathogenesis of fibrosis and slow or arrest the progression of the important diseases they underlie.

Entities:  

Keywords:  Adenosine; Collagen; Fibrosis; Scar; Wound

Mesh:

Substances:

Year:  2016        PMID: 26847815      PMCID: PMC4854836          DOI: 10.1007/s11302-016-9498-3

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  60 in total

1.  Adenosine A2A receptors in diffuse dermal fibrosis: pathogenic role in human dermal fibroblasts and in a murine model of scleroderma.

Authors:  E S L Chan; P Fernandez; A A Merchant; M C Montesinos; S Trzaska; A Desai; C F Tung; D N Khoa; M H Pillinger; A B Reiss; M Tomic-Canic; J F Chen; M A Schwarzschild; B N Cronstein
Journal:  Arthritis Rheum       Date:  2006-08

2.  The peripheral cannabinoid receptor 1 antagonist VD60 efficiently inhibits carbon tetrachloride-intoxicated hepatic fibrosis progression.

Authors:  Yan Wei; Xiao-li Kang; Xu Wang
Journal:  Exp Biol Med (Maywood)       Date:  2014-01-23

Review 3.  International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update.

Authors:  Bertil B Fredholm; Adriaan P IJzerman; Kenneth A Jacobson; Joel Linden; Christa E Müller
Journal:  Pharmacol Rev       Date:  2011-02-08       Impact factor: 25.468

4.  A protective role for the A1 adenosine receptor in adenosine-dependent pulmonary injury.

Authors:  Chun-Xiao Sun; Hays W Young; Jose G Molina; Jonathan B Volmer; Jurgen Schnermann; Michael R Blackburn
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

5.  Pharmacological blockade of adenosine A2A receptors diminishes scarring.

Authors:  Miguel Perez-Aso; Luis Chiriboga; Bruce N Cronstein
Journal:  FASEB J       Date:  2012-07-05       Impact factor: 5.191

6.  Adenosine A2A receptor agonists promote more rapid wound healing than recombinant human platelet-derived growth factor (Becaplermin gel).

Authors:  Cassandre Victor-Vega; Avani Desai; M Carmen Montesinos; Bruce N Cronstein
Journal:  Inflammation       Date:  2002-02       Impact factor: 4.092

7.  HIF-dependent induction of adenosine A2B receptor in hypoxia.

Authors:  Tianqing Kong; Karen A Westerman; Marion Faigle; Holger K Eltzschig; Sean P Colgan
Journal:  FASEB J       Date:  2006-11       Impact factor: 5.191

8.  The cyclic AMP effector Epac integrates pro- and anti-fibrotic signals.

Authors:  Utako Yokoyama; Hemal H Patel; N Chin Lai; Nakon Aroonsakool; David M Roth; Paul A Insel
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-23       Impact factor: 11.205

9.  The adenosine A1 receptor antagonist SLV320 reduces myocardial fibrosis in rats with 5/6 nephrectomy without affecting blood pressure.

Authors:  P Kalk; B Eggert; K Relle; M Godes; S Heiden; Y Sharkovska; Y Fischer; D Ziegler; G-W Bielenberg; B Hocher
Journal:  Br J Pharmacol       Date:  2007-06-11       Impact factor: 8.739

Review 10.  CD73 and adenosine generation in the creation of regulatory microenvironments.

Authors:  F S Regateiro; S P Cobbold; H Waldmann
Journal:  Clin Exp Immunol       Date:  2013-01       Impact factor: 4.330

View more
  25 in total

1.  Multiple adenosine receptor subtypes stimulate wound healing in human EA.hy926 endothelial cells.

Authors:  Zeinab Bonyanian; Matthew Walker; Eugene Du Toit; Roselyn B Rose'Meyer
Journal:  Purinergic Signal       Date:  2019-06-28       Impact factor: 3.765

2.  Adenosine A2a Receptor Blockade Diminishes Wnt/β-Catenin Signaling in a Murine Model of Bleomycin-Induced Dermal Fibrosis.

Authors:  Jin Zhang; Carmen Corciulo; Hailing Liu; Tuere Wilder; Mayumi Ito; Bruce Cronstein
Journal:  Am J Pathol       Date:  2017-06-28       Impact factor: 4.307

Review 3.  Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases.

Authors:  Bruce N Cronstein; Michail Sitkovsky
Journal:  Nat Rev Rheumatol       Date:  2016-11-10       Impact factor: 20.543

Review 4.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

5.  Epac is required for exogenous and endogenous stimulation of adenosine A2B receptor for inhibition of angiotensin II-induced collagen synthesis and myofibroblast differentiation.

Authors:  Sarawuth Phosri; Kwanchai Bunrukchai; Warisara Parichatikanond; Vilasinee H Sato; Supachoke Mangmool
Journal:  Purinergic Signal       Date:  2018-01-10       Impact factor: 3.765

6.  Myeloid Cell-Derived TGFβ Signaling Regulates ECM Deposition in Mammary Carcinoma via Adenosine-Dependent Mechanisms.

Authors:  Georgii Vasiukov; Tatiana Novitskaya; Andries Zijlstra; Philip Owens; Fei Ye; Zhiguo Zhao; Harold L Moses; Timothy Blackwell; Igor Feoktistov; Sergey V Novitskiy
Journal:  Cancer Res       Date:  2020-04-20       Impact factor: 12.701

7.  Adenosine A2A receptor promotes collagen type III synthesis via β-catenin activation in human dermal fibroblasts.

Authors:  Gibran Shaikh; Jin Zhang; Miguel Perez-Aso; Aranzazu Mediero; Bruce Cronstein
Journal:  Br J Pharmacol       Date:  2016-10-04       Impact factor: 8.739

8.  Loss of CD73 prevents accumulation of alternatively activated macrophages and the formation of prefibrotic macrophage clusters in irradiated lungs.

Authors:  Simone de Leve; Florian Wirsdörfer; Federica Cappuccini; Alexandra Schütze; Alina V Meyer; Katharina Röck; Linda F Thompson; Jens W Fischer; Martin Stuschke; Verena Jendrossek
Journal:  FASEB J       Date:  2017-03-21       Impact factor: 5.191

9.  Adenosine A2A receptor (A2AR) stimulation modulates expression of semaphorins 4D and 3A, regulators of bone homeostasis.

Authors:  Aránzazu Mediero; Tuere Wilder; Lopa Shah; Bruce N Cronstein
Journal:  FASEB J       Date:  2018-02-02       Impact factor: 5.191

10.  Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis.

Authors:  Andrew J Haak; Enis Kostallari; Delphine Sicard; Giovanni Ligresti; Kyoung Moo Choi; Nunzia Caporarello; Dakota L Jones; Qi Tan; Jeffrey Meridew; Ana M Diaz Espinosa; Aja Aravamudhan; Jessica L Maiers; Rodney D Britt; Anja C Roden; Christina M Pabelick; Y S Prakash; Seyed Mehdi Nouraie; Xiaoyun Li; Yingze Zhang; Daniel J Kass; David Lagares; Andrew M Tager; Xaralabos Varelas; Vijay H Shah; Daniel J Tschumperlin
Journal:  Sci Transl Med       Date:  2019-10-30       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.